[Experimental studies of the mechanism of action of chrysarobin and dithranol in psoriasis (evidence for a cytostatic effect on the epidermis)].
D000818:Animals; D000873:Anthracenes / Q000627:therapeutic use*; D001001:Anura; D002455:Cell Division / Q000187:drug effects; D002952:Citric Acid Cycle / Q000187:drug effects; D003576:Electron Transport Complex IV / Q000378:metabolism; D005260:Female; D005947:Glucose / Q000378:metabolism; D005954:Glucosephosphate Dehydrogenase / Q000378:metabolism; D006801:Humans; D007249:Inflammation / Q000209:etiology; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D008297:Male; D011565:Psoriasis / Q000188:drug therapy*; D012038:Regeneration / Q000187:drug effects; D012867:Skin / Q000187:drug effects* / Q000201:enzymology; D013385:Succinate Dehydrogenase / Q000378:metabolism; D014445:Tyrosine Decarboxylase / Q000378:metabolism
D000873:Anthracenes; D007770:L-Lactate Dehydrogenase; D005954:Glucosephosphate Dehydrogenase; D013385:Succinate Dehydrogenase; D003576:Electron Transport Complex IV; D014445:Tyrosine Decarboxylase; D005947:Glucose
Experimentelle Untersuchungen über den Wirkungsmechanismus von Chrysarobin und Dithranol bei Psoriasis (Indizien für eine cytostatische Wirkung an der Epidermis)